
International Journal of Nanomedicine, Journal Year: 2025, Volume and Issue: Volume 20, P. 6757 - 6775
Published: May 1, 2025
Head and neck cancer (HNC) represents approximately 10% of all cases globally, posing a significant public health challenge. Despite advances in therapeutic approaches, the mortality rate associated with HNC continues to rise. A growing body research highlights role extracellular vesicles progression pathogenesis, positioning them as promising candidates for novel biomarker discovery. Concurrently, saliva has emerged valuable diagnostic fluid due its non-invasive, accessible, cost-effective collection methods. This systematic review aims explore potential salivary tools early detection monitoring head cancer. PubMed, Scopus, Web Science, Embase were thoroughly searched from database inception July 16, 2024. Twenty-three eligible studies included, focusing on original that described biomarkers HNC. In oral - predominantly represented by squamous cell carcinoma subtype several proteins, including PSB7, AMER3, LOXL2, well ten-protein panel, demonstrated strong biomarkers. Additionally, analysis various microRNAs (miR-140, miR-143, miR-145, miR-412-3p, miR-512-3p, miR-1307-5p) Fourier-transform infrared (FTIR) spectra shown results detection. For oropharyngeal cancer, lactate dehydrogenase B appears be biomarker. Another avenue is assessment human papillomavirus (HPV) risk development Four investigated without specifying location; however, limited or absent reporting sensitivity specificity hampers reliable evaluation conclusion, hold promise HNC, but further needed validate their utility.
Language: Английский